Financial Network Wealth Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1K Buy
1,590
+400
+34% +$6.13K 0.03% 343
2026
Q1
$16.5K Buy
1,190
+181
+18% +$2.88K 0.02% 411
2025
Q4
$16.4K Buy
1,009
+401
+66% +$6.54K 0.02% 414
2025
Q3
$9.1K Buy
608
+103
+20% +$1.25K 0.01% 467
2025
Q2
$5.88K Hold
505
0.01% 498
2025
Q1
$3.75K Buy
505
+272
+117% +$2.09K ﹤0.01% 523
2024
Q4
$1.4K Buy
+233
New +$1.28K ﹤0.01% 434

Other funds holding ADPT

Financial Network Wealth Advisors's ADPT Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Adaptive Biotechnologies (ADPT) stake by 34% in Q2 2026, buying an estimated $6.13K and bringing the position to 1,590 shares worth $34.1K. The position accounts for 0.03% of the portfolio, ranked #343.

Financial Network Wealth Advisors first reported a position in ADPT in Q4 2024 and has held it in 7 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Financial Network Wealth Advisors held 1,590 shares of Adaptive Biotechnologies worth $34.1K as of Q2 2026.
  • Financial Network Wealth Advisors bought 400 Adaptive Biotechnologies shares in Q2 2026, an estimated $6.13K.
  • Adaptive Biotechnologies made up 0.03% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #343 holding.
  • Financial Network Wealth Advisors first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 7 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.